1046 completed, 498 unknown, 203 recruiting, 172 terminated. 2180 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2180 | Completed 1046, Unknown 498, Recruiting 203, Terminated 172, Not yet recruiting 112, Withdrawn 69, Active not recruiting 61, Enrolling by invitation 12, Suspended 7 |
Follow Neoplasms: new trials by email Literature Review of Neoplasms trials Research Report on Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Suzetrigine Versus Standard Analgesia After Skin Cancer Surgery Suzetrigine, Acetaminophen Plus Ibuprofen - Postoperative Pain, Acute Pain | Phase 4 | Not yet recruiting | University of Minnesota | 230 | 2027-04-01 | 2026-09-25 |
| BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases. teclistamab OR talquetamab OR elranatamab OR linvoseltamab, BTK inhibitors (ibrutinib and zanubrutinib) - Waldenstrom Macroglobulinaemia, Multiple Myeloma | Phase 4 | Not yet recruiting | Anne Louise Tølbøll Sørensen | 400 | 2027-03-01 | 2026-03-16 |
| Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain Biospecimen Collection, Low-Dose Aspirin, Patient Observation - Endometrial Carcinoma | Phase 4 | Not yet recruiting | Mayo Clinic | 20 | 2027-02-12 | 2026-08-05 |
| Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health. Gardasil 9 vaccine, Hepatitis B Virus Vaccine(HBV), Cognitive Behavioral Therapy - Hepatitis B, Human Papilloma Virus | Phase 4 | Not yet recruiting | Eunice Dube | 2140 | 2027-01-30 | 2026-07-30 |
| Efficacy of Zoster Vaccination in Glioblastoma Patients Additional vaccination against shingles (herpes zoster), Standard of care treatment without additional vaccination - Glioblastoma (GBM) | Phase 4 | Not yet recruiting | University Hospital, Essen | 230 | 2027-01-02 | 2026-04-23 |
| Evaluation of the Efficacy and Acceptability of a Phytotherapy Combining Devil's Claw, Blackcurrant and Meadowsweet for the Management of Aromatase Inhibitor-induced Arthralgia in Patients Treated for Localized Breast Cancer in the Adjuvant Setting Phytotherapy Dietary Supplement (Harpagophytum, Meadowsweet, and Blackcurrant), Patient Experience Questionnaire - Hormone Therapy-induced Arthralgia, Phytotherapy | Phase 4 | Not yet recruiting | Hospices Civils de Lyon | 105 | 2027-01-01 | 2026-10-05 |
| SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer GLP-1 Receptor Agonist, Levonorgestrel IUD (Lng-IUD), Oral Progestins - Endometrial Cancer, Endometrial Cancer Stage I | Phase 4 | Not yet recruiting | Hospital Universitari de Bellvitge | 80 | 2027-01-01 | 2026-06-10 |
| Remimazolam vs Propofol for Motor and Somatosensory Evoked Potentials in Spinal Tumor Surgery Remimazolam, Propofol - Spinal Cord Neoplasms, Spinal Neoplasms | Phase 4 | Not yet recruiting | Beijing Tsinghua Chang Gung Hospital | 190 | 2027-01-01 | 2026-10-28 |
| A Study of Zolbetuximab Given With mFOLFOX6 or CAPOX Chemotherapy in Indian Adults With Gastric Cancer Zolbetuximab, Oxaliplatin, Folinic Acid - Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Phase 4 | Not yet recruiting | Astellas Pharma Global Development, Inc. | 50 | 2026-11-30 | 2026-09-21 |
| A Study to Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Unresectable or Metastatic Melanoma Participants In India Nivolumab + Relatlimab - Unresectable Melanoma, Metastatic Melanoma | Phase 4 | Not yet recruiting | Bristol-Myers Squibb | 40 | 2026-11-15 | 2026-08-12 |
| Tucatinib Continuation Study tucatinib - HER2-positive Breast Cancer, Cervical Cancer | Phase 4 | Not yet recruiting | Pfizer | 175 | 2026-11-06 | 2026-08-28 |
| A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44) Pembrolizumab, Cisplatin, 5-Fluorouracil - Neoplasm Malignant, Gastric Neoplasms | Phase 4 | Not yet recruiting | Merck Sharp & Dohme LLC | 150 | 2026-11-06 | 2026-09-03 |
| Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer. Darolutamide, Physician choice Androgen Deprivation (Hormone) Therapy - Prostate Cancer | Phase 4 | Not yet recruiting | University of Chicago | 80 | 2026-11-01 | 2026-01-08 |
| Self-administered Subcutaneous Daratumumab in Patients With Multiple Myeloma The study intervention is self-administration of SC daratumumab by the patient, thereby changing the administration from an outpatient setting to a home setting. - Multiple Myeloma in Relapse | Phase 4 | Not yet recruiting | Odense University Hospital | 50 | 2026-11-01 | 2026-10-21 |
| A Phase IV Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma That is Not Responding to Four or More Standard Treatments or Has Come Back After Several Standard Treatments Elranatamab - Relapsed/Refractory Multiple Myeloma, Multiple Myeloma | Phase 4 | Not yet recruiting | Pfizer | 75 | 2026-10-22 | 2026-10-19 |
| Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFU Nuclear imaging (PSMA PET) with intravenous injection of a radiotracer one year after treatment (focal therapy) - Prostate Cancer - Recurrent, Prostate Cancer (Diagnosis) | Phase 4 | Not yet recruiting | University Hospital, Toulouse | 30 | 2026-10-01 | 2026-08-14 |
| A Study of QL1706 Combined With OH2 Injection in Perioperative Treatment of Stage III Resectable Acral Melanoma Iparomlimab and Tuvonralimab Injection (QL1706), OH2 Injection(Recombinant Human GM-CSF Oncolytic Type II Herpes Simplex Virus) - Melanoma, Acral Melanoma | Phase 4 | Not yet recruiting | Peking University Cancer Hospital & Institute | 76 | 2026-10-01 | 2026-10-02 |
| A Study of Selpercatinib (LY3527723) in Participants With Rearranged During Transfection (RET)-Altered Cancers in India Selpercatinib - Thyroid Neoplasms, Carcinoma, Non-Small-Cell Lung | Phase 4 | Not yet recruiting | Eli Lilly and Company | 30 | 2026-10-01 | 2026-10-08 |
| Assessing the Feasibility of Using Methylene Blue in Identifying Ureters During Colorectal Surgery Intravenous Methylene Blue, Methylene Blue Fluorescence Imaging System - Colorectal Cancer, Colorectal Surgery | Phase 4 | Not yet recruiting | Chinese University of Hong Kong | 20 | 2026-10-01 | 2026-10-06 |
| Pharmacokinetic Study of Pembrolizumab and Its Impact on Immunity and the Tumor Microenvironment, Which May Explain the Efficacy of Post-immunotherapy Chemotherapy. Blood sampling, Tumor biopsies for biobank establishment (optional) - Non-Small Cell Lung Carcinoma (NSCLC), Metastatic Head and Neck Squamous Cell Carcinoma | Phase 4 | Not yet recruiting | Centre Antoine Lacassagne | 110 | 2026-10-01 | 2026-09-15 |
Showing 20 of 2180. Sign in to see all of them.
Breast Neoplasms (280) · Prostatic Neoplasms (122) · Polycystic Ovary Syndrome (120) · Colorectal Neoplasms (106) · Carcinoma, Hepatocellular (105) · Carcinoma, Non-Small-Cell Lung (91) · Lung Neoplasms (73) · Stomach Neoplasms (66) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (60) · Neoplasm Metastasis (55) · Multiple Myeloma (54) · Keratosis, Actinic (46) · Pancreatic Neoplasms (46) · Head and Neck Neoplasms (44)
Neoplasms by Site (1299) · Neoplasms by Histologic Type (762) · Pathological Conditions, Signs and Symptoms (479) · Digestive System Diseases (463) · Urogenital Diseases (438) · Hemic and Lymphatic Diseases (424) · Digestive System Neoplasms (417) · Skin and Connective Tissue Diseases (410) · Skin Diseases (384) · Genital Diseases (364) · Pathologic Processes (333) · Female Urogenital Diseases and Pregnancy Complications (313) · Female Urogenital Diseases (311) · Hematologic Diseases (297)
Dexamethasone (53) · Metformin (52) · Cyclophosphamide (47) · Cytarabine (37) · Zoledronic Acid (33) · Letrozole (32) · Saline Solution (32) · Cisplatin (31) · Carboplatin (30) · Fluorouracil (29) · Vincristine (29) · Bevacizumab (28) · Docetaxel (28) · Doxorubicin (26) · Sodium Chloride (25)
Novartis Pharmaceuticals (62) · Hoffmann-La Roche (38) · Sun Yat-sen University (29) · AstraZeneca (23) · Pfizer (22) · M.D. Anderson Cancer Center (20) · Ottawa Hospital Research Institute (20) · PETHEMA Foundation (19) · University Magna Graecia (19) · GlaxoSmithKline (16) · Fudan University (15) · Mayo Clinic (15) · Seoul National University Hospital (15) · Merck Sharp & Dohme LLC (14) · Peking Union Medical College Hospital (14)
United States (498) · China (410) · Spain (120) · France (119) · Italy (117) · Germany (107) · Canada (103) · South Korea (102) · Netherlands (83) · United Kingdom (76) · Taiwan (71) · Denmark (64) · Egypt (63) · Poland (58) · India (56)
Stefano Palomba, MD (13) · Francesco Orio, MD (8) · Achille Tolino, MD (7)
PMID 32632956, PMID 38979716, PMID 36064577, PMID 36999619, PMID 41276263, PMID 11981766, PMID 12049862, PMID 12091661, PMID 12540794, PMID 15613435, PMID 15827109, PMID 17917842, PMID 19144982, PMID 19574236, PMID 19645909, PMID 21613624, PMID 22027076, PMID 22442346, PMID 22493293, PMID 23024237, PMID 23770157, PMID 23857221, PMID 24923295, PMID 25071111, PMID 26348120, PMID 26438146, PMID 27432417, PMID 27529295, PMID 27561722, PMID 28143456, PMID 28532759, PMID 28751559, PMID 28945881, PMID 31188797, PMID 32224746, PMID 33347618, PMID 33538338, PMID 34732660, PMID 35048355, PMID 36053283, PMID 37121591, PMID 37178368, PMID 37526194, PMID 10022643, PMID 10231138, PMID 10343249, PMID 10412031, PMID 10469005, PMID 10524880, PMID 10536559
2014 (13), 2023 (12), 2019 (11), 2025 (8), 2009 (7), 2016 (6), 2017 (6), 2015 (5), 2018 (4), 2004 (3), 2005 (3), 2008 (3), P30CA015704 (2), P30CA138292 (2), 1RC1HD063312-01 (1)